Small publication demonstrates that superior therapeutic profiles of CriPec® nanomedicines result from rational design Maastricht, The Netherlands, 11th May 2020 – Cristal Therapeutics, a Phase 2 clinical-stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announces the publication of a paper on its CriPec® nanomedicine technology […]
About Alex Jones
This author has yet to write their bio.Meanwhile lets just say that we are proud Alex Jones contributed a whooping 2 entries.
Entries by Alex Jones
September 12-14 EACR: Nanotechnology in Cancer Cambridge, UK